Who
Paul A. Laviolette
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Pulse Biosciences; Director, Edwards Lifesciences; Director, Misonix; Director, Asensus Surgical; Director, Thoratec; Director, Baxano Surgical; Director, Conceptus; COO, Boston Scientific.
In numbers
- Trades disclosed
- 96
- Buys
- 2
- Sells
- 5
- Bought
- $1.2M
- Sold
- $6.7M
- Companies
- 8
- Companies where not an officer
- 6
- First trade
- 26 Apr 2007
- Last trade
- 11 May 2026
- Last filed
- 11 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 May 2026filed 11 May 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $295K15,000 at $19.69 | filing |
| 11 May 2026filed 11 May 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $295K15,000 at $19.69 | filing |
| 11 May 2026filed 11 May 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $295K15,000 at $19.69 | filing |
| 11 May 2026filed 11 May 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $295K15,000 at $19.69 | filing |
| 8 May 2026filed 8 May 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,251 at $0.00 | filing |
| 8 May 2026filed 8 May 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,251 at $0.00 | filing |
| 9 May 2025filed 9 May 2025 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,528 at $0.00 | filing |
| 9 Jan 2025filed 13 Jan 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 9 Jan 2025filed 13 Jan 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,050,000 at $0.00 | filing |
| 9 Aug 2024filed 13 Aug 2024 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 9 Aug 2024filed 13 Aug 2024 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 8 May 2024filed 9 May 2024 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,055 at $0.00 | filing |
| 12 May 2023filed 15 May 2023 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —2,803 at $0.00 | filing |
| 4 May 2022filed 5 May 2022 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —2,300 at $0.00 | filing |
| 29 Oct 2021filed 8 Dec 2021 | Misonix | SEC FORM 4 Code D | —1,744,017 | filing |
| 1 Jul 2021filed 2 Jul 2021 | Asensus Surgical | SEC FORM 4 Code A | —13,846 at $0.00 | filing |
| 30 Jun 2021filed 2 Jul 2021 | Asensus Surgicaloption or derivative | SEC FORM 4 Code A | —10,025 at $0.00 | filing |
| 30 Jun 2021filed 2 Jul 2021 | Misonixoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 5 May 2021filed 7 May 2021 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —2,615 at $0.00 | filing |
| 31 Mar 2021filed 2 Apr 2021 | Asensus Surgicaloption or derivative | SEC FORM 4 Code A | —8,440 at $0.00 | filing |
News
Pulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule TreatmentPLSE · rttnews.com · 14 Oct 2026
0 headlines in the last 90 days name Paul A. Laviolette; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.